By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Chronic Kidney Disease have been presented. According to news reporting out of Honolulu, Hawaii, by NewsRx editors, research stated, "Chronic kidney disease (CKD) is a common, deadly, and expensive threat to public health. Patients susceptible to the development of CKD are difficult to identify because there are few noninvasive clinical techniques and markers to assess early kidney dysfunction."
Our news journalists obtained a quote from the research from the University of Hawaii, "Noninvasive imaging techniques are being developed to quantitatively measure kidney morphology and function in preclinical research and in clinical trials. Magnetic resonance imaging (MRI) techniques in particular have the potential to provide structural and functional information in the kidney. Novel molecular imaging techniques, using targeted magnetic nanoparticles that exploit the characteristics of the endogenous protein, ferritin, have been developed in conjunction with MRI to count every perfused glomerulus in the kidney and measure their individual volumes. This technique could open the door to the possibility of prospectively assessing and eventually reducing a patient's risk for progression to CKD."
According to the news editors, the research concluded: "This review highlights the potential clinical benefits of early detection in patients predisposed to CKD and discusses technologic and regulatory hurdles to the translation of these molecular MRI techniques to provide early diagnosis of CKD."
For more information on this research see: NIRI-Detectable Nanoparticles: The Potential Role in the Diagnosis of and Therapy for Chronic Kidney Disease. Advances in Chronic Kidney Disease, 2013;20(6):479-487. Advances in Chronic Kidney Disease can be contacted at: W B Saunders Co-Elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA. (Elsevier - www.elsevier.com; Advances in Chronic Kidney Disease - www.elsevier.com/wps/product/cws_home/703170)
Our news journalists report that additional information may be obtained by contacting J.R. Charlton, Univ Hawaii Manoa, Coll Nat Sci, Dept. of Biol, Honolulu, HI 96822, United States. Additional authors for this research include S.C. Beeman and K.M. Bennett (see also Chronic Kidney Disease).
Keywords for this news article include: Hawaii, Therapy, Honolulu, Nanoparticle, United States, Nanotechnology, Pre-Trial Research, Emerging Technologies, Chronic Kidney Disease, North and Central America, Clinical Trials and Studies
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC